An updated systematic review of studies mapping (or cross-walking) measures of health-related quality of life to generic preference-based measures to generate utility …
C Mukuria, D Rowen, S Harnan, A Rawdin… - … health economics and …, 2019 - Springer
Background Mapping is an increasingly common method used to predict instrument-specific
preference-based health-state utility values (HSUVs) from data obtained from another health …
preference-based health-state utility values (HSUVs) from data obtained from another health …
[HTML][HTML] Health utility values associated with surgical site infection: a systematic review
Background Surgical site infection (SSI) is a costly postoperative complication whose impact
on patients' health-related quality of life is highly uncertain and has not been summarized to …
on patients' health-related quality of life is highly uncertain and has not been summarized to …
[HTML][HTML] Condition-specific preference-based measures: benefit or burden?
MM Versteegh, A Leunis, CA Uyl-de Groot, EA Stolk - Value in Health, 2012 - Elsevier
Objectives Some argue that generic preference-based measures (PBMs) are not sensitive to
certain disease-specific improvements. To overcome this problem, new condition-specific …
certain disease-specific improvements. To overcome this problem, new condition-specific …
[HTML][HTML] Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma
I Proskorovsky, P Lewis, CD Williams, K Jordan… - Health and quality of life …, 2014 - Springer
Background In oncology, health-related quality of life (HRQoL) data are often collected using
disease-specific patient questionnaires while generic, patient-level utility data required for …
disease-specific patient questionnaires while generic, patient-level utility data required for …
Mapping EORTC-QLQ-C30 and QLQ-CR29 onto EQ-5D-5L in colorectal cancer patients
Purpose Patient-level utility data are needed for cost-utility analysis; in oncology, however,
the data are commonly gathered using disease-specific questionnaires that are often not …
the data are commonly gathered using disease-specific questionnaires that are often not …
[HTML][HTML] Mapping EORTC QLQ-C30 onto EQ-5D for the assessment of cancer patients
SH Kim, MW Jo, HJ Kim, JH Ahn - Health and quality of life outcomes, 2012 - Springer
Abstract Background The European Organisation for Research and Treatment of Cancer
Quality of Life Questionnaire Core 30 (EORTC QLQ-C30) is the instrument most frequently …
Quality of Life Questionnaire Core 30 (EORTC QLQ-C30) is the instrument most frequently …
[HTML][HTML] Quality of life of patients with chronic lymphocytic leukaemia in the Netherlands: results of a longitudinal multicentre study
KM Holtzer-Goor, MR Schaafsma, P Joosten… - Quality of Life …, 2015 - Springer
Purpose To describe the health-related quality of life (HRQoL) of an unselected population
of patients with chronic lymphocytic leukaemia (CLL) including untreated patients. Methods …
of patients with chronic lymphocytic leukaemia (CLL) including untreated patients. Methods …
Mapping functions in health-related quality of life: mapping from two cancer-specific health-related quality-of-life instruments to EQ-5D-3L
TA Young, C Mukuria, D Rowen… - Medical Decision …, 2015 - journals.sagepub.com
Background. Clinical trials in cancer frequently include cancer-specific measures of health
but not preference-based measures such as the EQ-5D that are suitable for economic …
but not preference-based measures such as the EQ-5D that are suitable for economic …
[HTML][HTML] Mapping onto Eq-5 D for patients in poor health
MM Versteegh, D Rowen, JE Brazier… - Health and Quality of life …, 2010 - Springer
Background An increasing amount of studies report mapping algorithms which predict EQ-5
D utility values using disease specific non-preference-based measures. Yet many mapping …
D utility values using disease specific non-preference-based measures. Yet many mapping …
Everolimus, lutetium-177 DOTATATE and sunitinib for advanced, unresectable or metastatic neuroendocrine tumours with disease progression: a systematic review …
R Mujica-Mota, J Varley-Campbell… - Health Technology …, 2018 - discovery.ucl.ac.uk
Background: Neuroendocrine tumours (NETs) are a group of heterogeneous cancers that
develop in cells in the diffuse neuroendocrine system. Objectives: To estimate the clinical …
develop in cells in the diffuse neuroendocrine system. Objectives: To estimate the clinical …